Localized Scleroderma: 111 Clinical Trials, Page 11 of 12

Hide Studies Not Open or Pending


A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Condition(s):Systemic Sclerosis; Scleroderma; Diffuse Systemic Sclerosis; Diffuse Scleroderma; Diffuse Cutaneous Systemic Sclerosis; Diffuse Cutaneous Scleroderma; Progressive Systemic Sclerosis; Progressive Scleroderma; Scleroderma, Systemic; Scleroderma, Diffuse; Scleroderma;Progressive; Systemic Sclerosis, Diffuse; Systemic; Sclerosis, Progressive; Scleroderma of Lung; Scleroderma With Pulmonary Involvement; Systemic Sclerosis Pulmonary; Systemic Sclerosis With Lung Involvement; Interstitial Lung Disease; Pulmonary Fibrosis InterstitialLast Updated:May 4, 2021Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.